June 13, 2013 ·
Leave a comment
June 13, 2013 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in gastroenterology with a leading U.S. biopharmaceutical company.
The company, a global leader in drug development for products aiding patients in recovery from a variety of gastrointestinal surgeries, approached Thought Leader Select for support with planned initiatives with key opinion leaders and centers of excellence in the field.
Thought Leader Select is identifying and profiling thought leaders in colorectal and general surgery across the United States. The in-house research group at Thought Leader Select is applying its objective, validated methodology to assess the skills and experiences, as well as the clinical and research interests, of KOLs specializing in surgery of the colon, rectum, and bowels.
Known for the versatility of applications for its in-house research, Thought Leader Select’s advisory team will also plan engagement strategies to optimize the talents and contributions that the key opinion leaders will bring to several initiatives for the client company, including late-stage clinical trial work, as well as publication and speaking opportunities. The KOLs will also work on issues within appropriate regulatory bodies, as well as patient advocacy and awareness, and treatment guidelines involvement.
In addition to its work with key opinion leaders, Thought Leader Select’s research group ... read more »
TAGS: 
advisory boards basic research biopharmaceutical biotechnology centers of excellence clinical research clinical trials gastroenterological surgery gastroenterology experts gastroenterology KOLs health care professionals health care providers key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts Neil Mellor pharma pharmaceutical physicians therapeutic areas Thought Leader Select thought leaders
May 29, 2013 ·
Leave a comment
We were inspired by a recent PharmaLive story on Lilly’s new initiative highlighting the key work that medical professionals undertake at the company during all facets and phases of drug discovery and development.
The story notes that over 500 physicians, 700 pharmacists, and 1400 medical research scientists work at Lilly, and the company is touting their work with the medical community to bring new treatments to market, all while keeping patient needs first.
While many are either skeptical or unaware of these interactions, the article speaks to why we are in the business of what we do at Thought Leader Select—delivering key information to pharmaceutical, biotechnology, and medical device companies so that external relations officials at companies like Lilly can optimize their medical community interactions in the service of patients.
Companies in life science disciplines utilize key opinion leaders in medicine in a host of ways to ensure that new treatments target unmet medical needs and have the best impact possible on patient outcomes. Their collaborative work results in clinical research, patient advocacy, bioethics, regulatory compliance, and medical education, all key drivers in medicine today.
Thought Leader Select is proud that our work in identifying and profiling the right key opinion leaders and medical centers of excellence to collaborate with industry in these many contexts and more optimizes these industry/medical community relationships for ... read more »
TAGS: biopharmaceutical biotechnology Eli Lilly ethics and transparency health outcomes industry-based medical professionals key opinion leaders in medicine KOL engagement KOLs Lilly medical device medical research scientists medical treatments patient care Patients Matter Most pharmaceuticals pharmacists PharmaLive physicians Thought Leader Select
May 21, 2013 ·
Leave a comment
Thought Leader Select is pleased to announce its sponsorship of the upcoming Canadian Business Association event featuring former Quintiles chief Sandy Costa.
Founded in 2009 by a group of Canadian business leaders based in the state’s Research Triangle region, the Canadian Business Association of North Carolina (CBANC) is an exchange where business leaders meet to share knowledge, connect, network, and build awareness of the significance of the US-Canadian relationship. CBANC produces a number of events featuring prominent Canadians, including executives and politicians.
The latest event, slated for June 5 at 5:30 pm at the RTP campus of Medicago USA, features Santo J. “Sandy” Costa, a former executive at Glaxo, Inc. (now GlaxoSmithKline) and Quintiles Transnational Corp in the Triangle. An acclaimed author, speaker, and attorney, Mr. Costa’s business experience includes over 40 years in various executive roles in the pharmaceutical, health care, and life sciences industries, as well as time spent as a practicing attorney.
Mr. Costa currently serves as Of Counsel to the law firm Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan of Raleigh. In addition to his ongoing professional work as an attorney, Mr. Costa serves on several boards of directors for publicly-traded and privately-held companies.
Mr. Costa continues to impact the Triangle area on a number of fronts, serving as an adjunct professor in the clinical research program at ... read more »
TAGS: Campbell University School of Pharmacy Canadian Business Association of North Carolina CBANC Duke Brain Tumor Center Duke Cancer Patient Support Program Glaxo health care industry life sciences industry Paul Meade pharmaceutical industry Quintiles Research Triangle Sandy Costa Thought Leader Select UNC Thurston Arthritis Research Center
April 17, 2013 ·
Leave a comment
Industry Insights from Paul Meade, M.Sc, MPH
Allison Murphy and I had the pleasure of participating in the MSL Society’s inaugural global conference and gala in Philadelphia earlier this month. At Thought Leader Select, we always enjoy the opportunity to meet some of our great colleagues in medical affairs in the pharmaceutical, biotechnology, and device industries, but this event proved to be really special.
Since joining our company last year, Allison has continued to make a real impact in the medical affairs community. After serving much of the last decade in Eli Lilly’s medical affairs division in support of the company’s endocrinology portfolio, Allison has brought a wealth of medical affairs expertise to Thought Leader Select. This expertise has continued to evolve, even as a consultant, through her membership and advisory board participation with the MSL Society, a dynamic group that we are proud to support as a company.
Dr. Samuel Dyer, the founder and head of the MSL Society, approached us a few months ago, asking for help with the burgeoning organization’s first global event. As a veteran of the industry myself, I have participated in many events through the years, as a participant, speaker, and sponsor. I must admit that I was more than a little skeptical about another conference/event series emerging in a space with ... read more »
TAGS: Allison Murphy Bayer biotechnology clinical trials CROs David Cram diagnostics Eli Lilly Global Prairie key opinion leaders in medicine KOL collaborations KOL engagement KOL strategy medical affairs medical devices medical science liaisons Mitch Trujillo MSL Society MSL Society Global Conference and Gala MSLs Paul Meade pharmaceuticals Quintiles Samuel Dyer Stewart Rosen Thought Leader Select thought leaders in medicine
February 26, 2013 ·
Leave a comment
For Immediate Release
February 21, 2013 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina-based key opinion leader strategy company, announces the hiring of Heather Langan as research director.
In her new role at the company, Langan will lead profiling and engagement planning related to the skills and experience of both leading physicians and other health care professionals, as well as medical centers of excellence that advance the medical science. Life sciences companies use this research and advice for better strategic decision-making for collaborations with medical experts, as industry works with these experts to bring new treatments to market for better patient care and better public health outcomes.
Langan arrives at Thought Leader Select after a decorated career in human services, working and leading teams in developmental disabilities, family therapy, and mental health. In her most recent role at Duke University’s National Center for Child Traumatic Stress, Langan led quality assurance and continuous improvement at the premier center of excellence in the area of child trauma, influencing the treatment decisions in evidence-based clinics around the country.
Heather Langan holds two bachelor’s degrees, in philosophy and psychology, from the University of Utah. After graduation, Langan also earned a pair of master’s degrees in psychology and counseling, from Stephen F. Austin University and North ... read more »
TAGS: biopharmaceutical centers of excellence developmental disabilities Duke University family therapy health care professionals Heather Langan Human Services key opinion leaders KOL engagement KOL engagement planning KOL identification KOL profiling leading physicians medical research medicine mental health National Center for Child Traumatic Stress patient care Paul Meade public health outcomes Thought Leader Select
February 7, 2013 ·
Leave a comment
For Immediate Release
February 7, 2013 (Chapel Hill, NC) The Medical Science Liaison Society (MSL Society) is planning its first global conference and gala for April 2013.
The event will take place at Philadelphia’s Hyatt at the Broadview on South Broad Street, from April 1-3. The 2013 MSL Society Conference and Gala is the first event of its kind, a tangible extension of the non-profit organization’s mission to bring together global medical affairs professionals for education and networking in an effort to support the profession.
Attendees will include Medical Affairs and MSL Leadership, as well as other professionals focusing on key topic including KOL access, HEOR, clinical trials, clinical investigation, key opinion leader relationship management, and medical communications. The emerging roster of speakers includes luminaries from the world of medical affairs, including Dr. Stewart Rosen, Vice President of Medical Affairs at Quintiles, Dr. Robert Ang, Vice President of Medical Affairs at Cadence Pharmaceuticals, and Dr. Elizabeth Kupferer, Director of Medical Affairs at Sequenom. 
Highlights of the three-day event include a welcome reception on day one, followed by a full day of education and networking, the gala dinner to culminate day two, and a final round of education and networking on day three.
“We’ve planned our first live conference with the needs ... read more »
TAGS: Allison Murphy biotechnology Cadence Pharmaceuticals clinical investigation clinical trials Elizabeth Kupferer HEOR key opinion leaders KOL management KOLs Kristen Smithwick medical affairs medical affairs education medical affairs networking medical devices medical science liaisons MSL leadership MSL Society MSL Society Global Conference and Gala patient health pharmaceuticals public health Quintiles Robert Ang Samuel Dyer Sequenom Stewart Rosen Thought Leader Select thought leaders in medicine
December 20, 2012 ·
Leave a comment
December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs. Among these ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology chronic obstructive pulmonary disorder clinical trials COPD deep-profiling health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs medical devices Neil Mellor oncology KOLs pharmaceutical pharmaceuticals physicians pulmonology rheumatology KOLs Thought Leader Select thought leaders treatment guidelines
November 15, 2012 ·
Leave a comment
The Medical Science Liaison Society, a non-profit focused on advancing the Medical Science Liaison career in the pharmaceutical, biotechnology, and medical device industries, has named Thought Leader Select’s Allison Murphy to its global advisory committee.
The MSL Society, led by Dr. Samuel Dyer from its Florida headquarters, is bringing the global MSL community together through a variety of educational and networking platforms, including webinars, white papers, conferences, and multiple social media outlets. Dr. Dyer and the MSL Society team of advisors are collaborating with several premier industry partners, including First Word Reports and EyeforPharma.
Prior to joining Thought Leader Select as a global sales consultant in 2012, Murphy spent the previous decade of her career working as a Medical Science Liaison at Eli Lilly and Company in the therapeutic area of Endocrinology. Murphy collaborated with multiple Key Opinion Leaders to drive Lilly’s medical initiatives in support of products aimed at treating conditions ranging from diabetes to growth disorders.
“I am very proud to be a part of the MSL Society’s global advisory committee,” stated Murphy. “I know first-hand from my days at Lilly that there weren’t enough of the right resources and networking opportunities for MSLs and Medical Affairs executives, to help them advance their careers and ... read more »
TAGS: Allison Murphy biotechnology diabetes Eli Lilly and Company endocrinology EyeforPharma First Word Reports growth disorders key opinion leaders medical affairs medical devices Medical Science Liaison Society medical science liaisons MSL education MSL networking MSL resources MSLs pharmaceuticals Samuel Dyer Thought Leader Select
November 6, 2012 ·
Leave a comment
November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of excellence in women’s health with an international biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products aimed at improving the health of women, approached Thought Leader Select for support in a variety of collaborative efforts with leading physicians and other health care professionals at leading universities, medical schools, teaching hospitals, and specialty clinics. The key opinion leaders represent medical experts within the Canadian obstetrics and gynecology community, with areas of sub-specialty including fertility and the treatment of uterine tumors.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, to advance the science of medicine and patient care in women’s health, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening collaborative ... read more »
TAGS: biopharmaceutical company biotechnology Canadian KOLs centers of excellence Chapel Hill NC clinical research clinical trials deep-profiling drug development gynecology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs Kristen Smithwick medical experts medical research obstetrics scientific journal publishing Thought Leader Select thought leaders transparency treatment guidelines uterine tumors women's health
October 30, 2012 ·
Leave a comment
Thought Leader Select is a company focused on driving industry collaborations among biopharmaceutical, medical device, and diagnostics companies with leading medical experts and centers of excellence, with the ultimate goals of these collaborations being two-fold in purpose: better treatment options for patients and better outcomes for global public health. As part of our company’s mission, we work with multiple organizations to promote best practices that deliver ethical, transparent interactions among these various healthcare constituencies.
One of these groups is the recently-launched Medical Science Liaison Society, a global Non-Profit organization being led by the Chairman of the Board, Dr. Samuel Dyer. The MSL Society is filling a vital need for the expanding role of Medical Science Liaisons around the world, as they collaborate with KOLs, physicians, and other health care professionals to advance medical science together to improve the quality of life for patients everywhere.
Thought Leader Select’s Allison Murphy, a veteran MSL herself from her days working in the Endocrinology Medical Affairs unit at Eli Lilly and Company, recently sat down with Dr. Dyer to learn more about this emerging organization and the impact the MSL Society is having in promoting the role of Medical Science Liaisons in the pharmaceutical, biopharmaceutical, medical device, and diagnostics industries.
In ... read more »
TAGS: Allison Murphy biotechnology centers of excellence CRO Eli Lilly and Company health care professionals healthcare key opinion leader management key opinion leader relationships key opinion leaders KOLs medical affairs medical affairs conference medical device medical science Medical Science Liaison Society medical science liaisons MSL and Medical Affairs Networking Group LinkedIn MSL best practices MSL conferences MSL education MSL executives MSL experts MSL management MSL resources MSL World group LinkedIn off-label discussions pharmaceutical physicians publications Samuel Dyer scientific journals social media Thought Leader Select University of North Carolina at Chapel Hill School of Medicine
Older posts »
